Artelo Biosciences Enters Consulting Agreement with ABK Labs for Digital Asset Strategy

ARTELO BIOSCIENCES, INC.

Artelo signed a 4-year consulting agreement with ABK Labs for strategic advisory on digital asset strategy, business development, and investor relations.
Company agreed to issue warrants to purchase 55,000 shares at $10.20 per share, subject to board approval and performance milestones.
Warrants vest in tranches based on continued service and achievement of market capitalization thresholds, with acceleration provisions.
ABK Labs will advise on digital asset allocation, partnerships, financial modeling, and communication of Artelo's digital asset strategy.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.